Bioniq secured a $7.8 million Series A investment led by venture capital firm OKS Group

Bioniq, a London, UK-based company providing supplement subscriptions and at-home testing services, announced that it secured a series A funding round of $7.8 million.

The money was raised from the Russian-based investment company OKS Group.

Bioniq, founded in 2019 by two Russians Vadim Fedotov and Konstantin Karusin, provides a supplement subscriptions and at-home testing services, via two personalised products - bioniq life and bioniq balance. In addition, the company also offers bioniq immune, an immune support complex. The company has partnered in the USA with Lenco Diagnostic Laboratories in more than 20 locations across the East Coast, along with doctors and a fitness club chain.